Skip to content

Ultra-early steroid tape intervention for preventing hypertrophic scars after TKA: a randomized controlled trial

Ultra-early steroid tape intervention for preventing hypertrophic scars after total knee arthroplasty: a randomized controlled trial - UST-TKA Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061193
Enrollment
110
Registered
2026-04-08
Start date
2026-04-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the knee

Interventions

Delayed intervention group (Control) Delayed initiation of steroid tape therapy starting at 3 months after total knee arthroplasty. Steroid tape is applied from postoperative month 3 as part of stand

Sponsors

Yoshinori Mikashima
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Key inclusion criteria 1. Patients undergoing primary total knee arthroplasty for knee osteoarthritis. 2. Patients with a fully epithelialized incision and no signs of infection at 1 month postoperatively. 3. Patients who wish to receive steroid tape therapy and provide written informed consent. 4. Patients who are able to complete follow-up assessments up to 6 months after surgery.

Exclusion criteria

Exclusion criteria: Exclusion criteria - Patients who show any signs of wound infection (e.g., erythema, discharge, warmth) at 1 month postoperatively. - Patients whose incision is not fully epithelialized and for whom steroid tape application is not considered safe. - Patients with known allergies to topical steroids or adhesive materials used in the tape. - Patients receiving immunosuppressive therapy or systemic corticosteroid treatment. - Patients with severe dermatologic conditions that may affect wound healing. - Patients undergoing revision TKA or those with infectious arthritis or other non-primary TKA indications. - Patients who are unlikely to complete follow-up assessments up to 6 months after surgery. - Patients who are unable or unwilling to provide written informed consent.

Design outcomes

Primary

MeasureTime frame
Thickness of the hypertrophic scar (mm) at 6 months postoperatively.

Countries

Japan

Contacts

Public ContactYoshinori Mikashima

Takagi Hospital Oume Knee Surgery Center

ymikashima2007@yahoo.co.jp0428315255

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026